Precision medicines biotech Relay Therapeutics is shedding about 10% of its workforce in efforts to streamline the ...

The digital pathology developer Proscia is launching an artificial intelligence toolkit for life science researchers, ...

One of those companies, a contract research organization focused on genetic medicines called Franklin Biolabs, officially ...

Kurma plans to raise a total of 250 million euros ($276 million) for the fund, dubbed Biofund IV, which would make it the ...

Septerna is about to find out how a biotech without “any meaningful clinical data” fares in the late 2024 IPO market. | ...

Legend Biotech appears to be on a mission to shake up its cell therapy development. | A week after signing up to collaborate ...

Siemens Healthineers has received a new go-ahead from the FDA for what the company describes as its first completely ...

Pentixapharm has brought in almost 20 million euros ($22 million) from an IPO, with the German biotech earmarking the ...

GigaGen’s prior work with the DOD produced polyclonal antibodies that can neutralize two botulinum neurotoxins, which are ...

The COVID-19 pandemic made the public acutely aware of how vulnerable their noses are. | The COVID-19 pandemic made us ...

Big Pharma is investing heavily in AI to slash development timelines and foster innovation. | Big Pharma is investing heavily ...

Frazier Life Sciences has sourced a further $630 million for its fund focused on small and mid-cap biotechs. | Frazier Life ...